BetterLife Pharma Inc
BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company's products pipeline includes BETR-001 for the t… Read more
Market Cap & Net Worth: BetterLife Pharma Inc (BETRF)
BetterLife Pharma Inc (OTCQB:BETRF) has a market capitalization of $8.35 Million ($8.35 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #30830 globally and #10155 in its home market, demonstrating a -12.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BetterLife Pharma Inc's stock price $0.06 by its total outstanding shares 151896675 (151.90 Million).
BetterLife Pharma Inc Market Cap History: 2015 to 2025
BetterLife Pharma Inc's market capitalization history from 2015 to 2025. Data shows change from $151.90 Million to $8.35 Million (-25.92% CAGR).
BetterLife Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BetterLife Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BETRF by Market Capitalization
Companies near BetterLife Pharma Inc in the global market cap rankings as of March 18, 2026.
Key companies related to BetterLife Pharma Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
BetterLife Pharma Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, BetterLife Pharma Inc's market cap moved from $151.90 Million to $ 8.35 Million, with a yearly change of -25.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.35 Million | -39.56% |
| 2024 | $13.82 Million | +89.58% |
| 2023 | $7.29 Million | -60.66% |
| 2022 | $18.53 Million | -28.24% |
| 2021 | $25.82 Million | -89.24% |
| 2020 | $240.00 Million | +1269.15% |
| 2019 | $17.53 Million | -46.15% |
| 2018 | $32.55 Million | -90.39% |
| 2017 | $338.73 Million | +1927.27% |
| 2016 | $16.71 Million | -89.00% |
| 2015 | $151.90 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BetterLife Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.35 Million USD |
| MoneyControl | $8.35 Million USD |
| MarketWatch | $8.35 Million USD |
| marketcap.company | $8.35 Million USD |
| Reuters | $8.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.